Matrix metalloproteinases: new routes to the use of MT1-MMP as a therapeutic target in angiogenesis-related disease.
published in: Current Pharmaceutical Design
date of publication: 2007-01-01
Cites articles
There is nothing here
Article - wd:Q36855678